General Information of This Metabolic Reaction (MR) (ID:
MR001803) |
Formula |
|
Reactant |
Olanzapine |
Product |
4'-N-desmethylolanzapine |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 1A2 (CYP1A2)
|
DME Info
|
Metabolic Type
|
Oxidation
-
N-Demethylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
Olanzapine. Pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinet. 1999 Sep;37(3):177-93.
|
2 |
The Unique Human N10-Glucuronidated Metabolite Formation from Olanzapine in Chimeric NOG-TKm30 Mice with Humanized Livers. Drug Metab Dispos. 2023 Apr;51(4):480-491. doi: 10.1124/dmd.122.001102.
|
3 |
Quantification of olanzapine and its three metabolites by liquid chromatography-tandem mass spectrometry in human body fluids obtained from four deceased, and confirmation of the reduction from olanzapine N-oxide to olanzapine in whole blood in vitro. Forensic Toxicol. 2023 Jul;41(2):318-328. doi: 10.1007/s11419-023-00662-0.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.